Massachusetts · Nonprofit
COMMONWEALTH CANCER CONSORTIUM INC
COMMONWEALTH CANCER CONSORTIUM INC (Massachusetts) receives grants from 11 organizations whose IRS filings report $90,628,909 to it, the largest being COMMONWEALTH FOUNDATION FOR CANCER RESEARCH ($83,383,774). 4 of them have funded it in more than one year.
- Revenue FY2024
- $13M
- Funders on record
- 11
- Grants received
- $91M
- Net assets
- $56M
What Commonwealth Cancer Consortium Inc does
Mission
Break through cancer is a foundation dedicated to supporting translational research in the most difficult to treat cancers. Our partner organizations are among the top cancer research centers and together, represent some of the most brilliant, creative minds in the country. We believe break through cancer is the beginning of a scientific movement that accepts nothing less than multi-institutional collaboration in patient centric cancer research. The foundation will work closely with teams of scientists, engineers, and clinical researchers to focus on diagnosing, treating, and ideally curing some of the most intractable forms of cancer. While many patients have benefited from advances in research and technology, there are too many who have been left behind. There are too many cancers where the needle remains unmoved. Break through cancer is committed to making headway in these extremely complex, challenging diseases, and committed to finding hope for patients and their families.
As stated on its FY2024 Form 990.
Program
Provides funding to teams of researchers from the five top cancer research centers: dana-farber cancer institute, the sidney kimmel comprehensive cancer center at john hopkins, massachusetts institute of technology's koch institute for integrative cancer research, the university of texas md anderson cancer center, and memorial sloan kettering cancer center in order to help intercept cancer early, develop more effective treatments, and accelerate cures for some of the deadliest cancers.
$26,250,079 spent$13,409,685 earned by the program100% of program spending
The program described on its FY2024 Form 990. Program spending in total: $26,250,079.
The organization over time
Each line starts at 100 in 2020, so what you read is the shape rather than the size: 150 means half as much again as 2020, 50 means half. The number beside each label in the key is where it ended.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2022 to 2023, from $102M to $73M (−28%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 2 of the last 5 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2021 → 2023: the base held at 3 funders, grant income rose $2.2M → $29M.
8 of 11 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 1% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of COMMONWEALTH CANCER CONSORTIUM INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
COMMONWEALTH CANCER CONSORTIUM INC leans on a few funders — its largest provides 92% of grant income and the top three 99%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund COMMONWEALTH CANCER CONSORTIUM INC.
Largest funder’s share by year: 2021 99% · 2022 84% · 2023 100% — broadly stable.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
COMMONWEALTH CANCER CONSORTIUM INC draws 100% of its grant income from funders outside Massachusetts, across 3 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.2M arriving through sponsors registered in 5 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Organizations like COMMONWEALTH CANCER CONSORTIUM INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Massachusetts
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
91% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 6 states
Screen this organization
A dated, signed PDF of the compliance screen for COMMONWEALTH CANCER CONSORTIUM INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds COMMONWEALTH CANCER CONSORTIUM INC?
- COMMONWEALTH CANCER CONSORTIUM INC (Massachusetts) receives grants from 11 organizations whose IRS filings report $90,628,909 to it, the largest being COMMONWEALTH FOUNDATION FOR CANCER RESEARCH ($83,383,774). 4 of them have funded it in more than one year.
- How many funders does COMMONWEALTH CANCER CONSORTIUM INC have?
- IRS filings report 11 organizations giving $90,628,909 in grants to COMMONWEALTH CANCER CONSORTIUM INC, 4 of which have funded it in more than one year.
- Who is the largest funder of COMMONWEALTH CANCER CONSORTIUM INC?
- COMMONWEALTH FOUNDATION FOR CANCER RESEARCH is the largest funder on record, with $83,383,774 in grants. The full list of funders is on this page.
- How can an organization like COMMONWEALTH CANCER CONSORTIUM INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Massachusetts. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds Commonwealth Cancer Consortium →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2020–2024), and the filings of 11 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing